AZTA
HealthcareAzenta, Inc.
$35.75
+$2.36 (+7.07%)
Jan 5, 2026
Price History (1Y)
Analysis
Azenta, Inc. is a healthcare company operating in the medical instruments and supplies industry. With a market capitalization of $1.64 billion, it has a substantial scale, employing approximately 3,000 individuals. Azenta's revenue for the trailing twelve months (TTM) stands at $593.82 million. From a financial health perspective, Azenta exhibits mixed profitability indicators. Its gross margin is 45.5%, while its operating and profit margins are significantly lower at 1.1% and -9.4%, respectively. In terms of returns, the company's return on equity (ROE) is 1.4%, but it has a negative return on assets (ROA) of -0.6%. The balance sheet shows $340.92 million in cash and $59.93 million in debt, resulting in a debt-to-equity ratio of 3.47. Azenta's valuation can be assessed through its price-to-earnings (P/E) ratios. Its P/E ratio for the trailing twelve months is 62.72, while the forward P/E is slightly lower at 35.22. Revenue growth over the past year has been 5.2%. Notably, Azenta does not pay dividends, as indicated by a payout ratio of 0.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Azenta, Inc.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Visit website →Key Statistics
- Market Cap
- $1.64B
- P/E Ratio
- 62.72
- 52-Week High
- $55.64
- 52-Week Low
- $23.91
- Avg Volume
- 614.64K
- Beta
- 1.31
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NMS
- Country
- United States
- Employees
- 3,000